Compare InMode Ltd (INMD) vs Manulife Financial Corporation (MFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
InMode Ltd vs Manulife Financial Corporation — how do they compare? InMode Ltd trades at $14.21 (market cap $809.93M), while Manulife Financial Corporation trades at $42.43 (market cap $69.48B). The key difference: Manulife Financial Corporation is far larger — about 85.8× InMode Ltd's market cap, and Manulife Financial Corporation pays a 3.23% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 28 Days and Manulife Financial Corporation for 119 Days on average.
| INMD | MFC | |
|---|---|---|
Market Cap | $809.93M | $69.48B |
Volume | 365,490 | 1,347,508 |
Sector | Health | Financials |
52-Week High | $16.62 | $44.77 |
52-Week Low | $12.76 | $31.64 |
Typical Hold Time | 28 Days | 119 Days |
Enterprise Value | $313.27M | $64.75B |
Dividend Yield | — | 3.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
InMode (INMD) trades at $14.08, up 0.5% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 76.5% gross margins and 20.7% net income margin, though Q1 2026 earnings missed expectations. Recent developments include the launch of Morpheus8 Cool technology and an unsolicited acquisition offer from Steel Partners at $16.75 per share in July 2026.
Investment outlook is cautiously optimistic with attractive valuation metrics (P/E 11.6, EV/EBITDA 4.5) offset by near-term revenue stagnation. Key risks include US platform sales decline and management capital allocation concerns. Analyst consensus leans neutral with 45% buy ratings and 55% hold, suggesting potential upside if the acquisition materializes or international growth accelerates.
MFC trades at $42.12, up 1.08% today, with a bearish technical signal from moving averages. Revenue grew to $53.01B in 2025, with a net income margin of 11.7%, while Q2 2026 earnings beat expectations. Analyst consensus is bullish with 57% buy ratings, though the consensus price target of $34.24 is below the current price. Recent news includes a new $750M subordinated notes offering and executive appointments.
Outlook is mixed: strong fundamentals and institutional interest support upside, but technical weakness and a high valuation relative to the price target pose risks. Key catalysts include Q3 2026 earnings and execution of growth initiatives in Asia.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →
